Execution VersionCertain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely causecompetitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.DEVELOPMENT AGREEMENTThis Development Agreement (“this Agreement”) is entered into and effective as of September 30, 2019 (“EffectiveDate”) by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics(“Stryker”), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology ParkDrive, Billerica, MA 01821 (“Conformis”). Stryker and Conformis are collectively referred to herein as the “Parties” andindividually as a “Party.”WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker’s purchase of certainConformis assets concerning Patient-Specific Instrumentation (“Asset Purchase Agreement”), and a License Agreement, aDistribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, suchagreements are referred to herein as the “Other Agreements”).WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered underthe trademark Triathlon.WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,including partial and total knee and hip arthroplasty.WHEREAS, Stryker desires that Conformis develop, in accordance with the RD Program, certain Patient-SpecificInstrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (suchPatient-Specific Instrumentation as so developed, the “KIB Product”).THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the OtherAgreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Partieshereby agree as follows:ARTICLE IDEFINITIONS1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extentnot defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the OtherAgreements:Source: CONFORMIS INC, 10-Q, 11/1/2019“Acceptance” and “Accept” have the meaning set forth in Article 3.4 of this Agreement.“Acceptance Criteria” has the meaning set forth in the RD Work Plan.“Acceptance Notification Period” has the meaning set forth in Article 3.3 of this Agreement."Affiliate" has the meaning set forth in the Asset Purchase Agreement."Agents" means Third Parties who are acting under the direction or control of a Party."Applicable Laws" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,writs, injunctions and decrees of any kind.“Asset Purchase Agreement” has the meaning set forth in the recitals.“Change of Control” has the meaning set forth in the Asset Purchase Agreement."Claims" has the meaning set forth in Article 7.3(a) of this Agreement."Confidential Information" has the meaning set forth in the Asset Purchase Agreement."Conformis Background IP" means any Invention, and all Intellectual Property rights underlying such Invention, that is,as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a thirdparty, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIBProduct, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP,Improved Stryker Background IP and Improved Conformis Background IP.2Source: CONFORMIS INC, 10-Q, 11/1/2019“Conformis Foreground IP” means any Invention first developed by Conformis after the Closing Date other than in theperformance of the RD Program, and all Intellectual Property rights underlying such Invention (for the avoidance of doubt,excluding any Intellectual Property rights subsisting prior to the Closing Date or generated in the performance of the RDProgram). For the avoidance of doubt, Conformis Foreground IP shall not include any Inventions using Stryker ConfidentialInformation (which shall not include the Purchased Assets for the purposes of the definition of Conformis Foreground IP) orStryker Background IP.“Conformis Indemnified Parties” has the meaning set forth in Article 7.3(b) of this Agreement.“Conformis-Prosecuted Joint IP Rights” has the meaning set forth in Article 5.8 of this Agreement.“Court” has the meaning set forth in the Asset Purchase Agreement.“Deliverables” has the meaning set forth under the RD Work Plan.“Disclosing Party” has the meaning set forth in the Asset Purchase Agreement.“Distribution Agreement” has the meaning set forth in the Asset Purchase Agreement.“Equipment” has the meaning set forth in Article 5.6(a) of this Agreement.“Failure Notice” has the meaning set forth in Article 3.4 of this Agreement.“Finally Rejects” has the meaning set forth in Article 3.4 of this Agreement.“Force Majeure Event” has the meaning set forth in Article 10.4(a) of this Agreement.3Source: CONFORMIS INC, 10-Q, 11/1/2019“Improved Conformis Background IP” means any Invention to the extent first arising in the performance of the RDProgram, whether or not embodied in the KIB Product, that constitutes an improvement to Conformis Background IP, ConformisConfidential Information (which shall not include any Confidential Information owned or commonly owned by Stryker) or thePurchased Assets, and all Intellectual Property rights underlying such Invention (but expressly excluding all Transferred IP,Conformis Foreground IP, Conformis Background IP and Stryker Background IP, and, for the avoidance of doubt, excluding allIntellectual Property rights subsisting prior to the Closing Date).“Improved Stryker Background IP” means any Invention to the extent first arising in the performance of the RDProgram, whether or not embodied in the KIB Product, that constitutes an improvement to Stryker Background IP or any StrykerConfidential Information (which shall not include the Purchased Assets for the purposes of this definition), and all IntellectualProperty rights underlying such Invention (but expressly excluding all Transferred IP, Conformis Foreground IP, ConformisBackground IP and Stryker Background IP, and, for the avoidance of doubt, excluding all Intellectual Property rights subsistingprior to the Closing Date).“Insolvency Event” means, with respect to any Party, the occurrence of any one of the following events:(i) an involuntary proceeding is commenced against such Party under any applicable United States bankruptcy, insolvency,reorganization or other similar United States or foreign law now or hereafter in effect, or a proceeding is commenced seekingappointment of a receiver, liquidator, assignee, custodian, trustee, sequestrator (or other similar official) for such Party or for all orany substantial part of its property and such proceeding shall not be dismissed within [] or an order for relief by a court ofcompetent jurisdiction shall be entered in any such proceeding; or(ii) such Party shall commence a voluntary proceeding under any applicable United States or foreign bankruptcy, insolvency,reorganization or other similar law now or hereafter in effect, or shall consent to the entry of an order for relief in an involuntarycase under any such law, or shall consent to the appointment of or taking possession by a receiver, liquidator,4Source: CONFORMIS INC, 10-Q, 11/1/2019assignee, custodian, trustee, sequestrator (or other similar official) of such Party or of all or any substantial part of its property, orshall make an assignment for the benefit of creditors."Intellectual Property" has the meaning set forth in the Asset Purchase Agreement."Invention" means any idea, invention, discovery, know-how, data, work of authorship, information, improvement,technology, process, concept or material, whether or not patentable, copyrightable or protectable as a trade secret, and whetheror not reduced to practice or memorialized in writing."Joint CI" has the meaning set forth in the Asset Purchase Agreement.“Joint IP” has the meaning set forth in Article 5.1(c) of this Agreement.“Joint IP Rights” has the meaning set forth in Article 5.8 of this Agreement.“KIB Product” has the meaning set forth in the recitals.“KIB Product IP” means any Invention first arising in the performance of the RD Program, whether or not embodied inthe KIB Product, and all Intellectual Property rights underlying such Invention (but expressly excluding all Transferred IP,Conformis Background IP, Stryker Background IP, Improved Conformis Background IP and Improved Stryker Background IP,and, for the avoidance of doubt, excluding all Intellectual Property rights subsisting prior to the Closing Date).“License Agreement” has the meaning set forth in the Asset Purchase Agreement.“Off-The-Shelf Implant” has the meaning set forth in the Asset Purchase Agreement.5Source: CONFORMIS INC, 10-Q, 11/1/2019“Off-The-Shelf Knee Implant” has the meaning set forth in the Asset Purchase Agreement.“Other Agreements” has the meaning set forth in the recitals.“Patents” has the meaning set forth in the Asset Purchase Agreement.“Patient-Specific Implants” has the meaning set forth in the Asset Purchase Agreement.“Patient-Specific Instrumentation” has the meaning set forth in the Asset Purchase Agreement."Person" has the meaning set forth in the Asset Purchase Agreement.“Prior CDA” has the meaning set forth in the Asset Purchase Agreement.“Purchased Assets” has the meaning set forth in the Asset Purchase Agreement.“Receiving Party” has the meaning set forth in the Asset Purchase Agreement.“Redelivery Period” has the meaning set forth in Article 3.4 of this Agreement."RD Program" means work performed in the development of the KIB Product under this Agreement pursuant to theRD Work Plan."RD Work Plan" means the research and development plan set forth in Exhibit 1.“Relevant Indemnified Parties” means (a) if Stryker is the indemnified Party, the Stryker Indemnified Parties and (b) ifConformis is the indemnified Party, the Conformis Indemnified Parties.6Source: CONFORMIS INC, 10-Q, 11/1/2019“Representatives” has the meaning set forth in the Asset Purchase Agreement."Stryker Background IP" means any Invention, and all Intellectual Property rights underlying such Invention, that is, asof the Effective Date owned or licensable by Stryker without causing a breach of, or incurring any obligation to, a third party, ineach case to the extent each such Invention is (a) necessary or reasonably useful to design, develop, manufacture, sell andotherwise exploit the KIB Product and (b) provided to Conformis by or on behalf of Stryker in connection with Conformis’activities under this Agreement, and, for the avoidance of doubt, excluding the Transferred IP, Conformis Background IP,Improved Conformis Background IP and Improved Stryker Background IP.“Stryker Indemnified Parties” has the meaning set forth in Article 7.3(a) of this Agreement.“Stryker-Prosecuted Joint IP Rights” has the meaning set forth in Article 5.8 of this Agreement."Termination Notice" means a written notice delivered by one Party to the other Party of its election to terminate thisAgreement pursuant to Article VIII."Third Party" has the meaning set forth in the Asset Purchase Agreement.“Trademarks” has the meaning set forth in the Asset Purchase Agreement.“Transferred IP” has the meaning set forth in the Asset Purchase Agreement.“Triathlon” has the meaning set forth in the Asset Purchase Agreement."Wire Instructions" has the meaning set forth in the Asset Purchase Agreement.7Source: CONFORMIS INC, 10-Q, 11/1/2019ARTICLE IIRESEARCH AND DEVELOPMENT PROGRAM2.1 RD Work Plan. The Parties agree to conduct the RD Program pursuant to the RD Work Plan and to performtheir respective obligations therein. To the extent Conformis’ performance under the RD Program is delayed due to Stryker’sdelay in performing any of its obligations in accordance with the timelines in the RD Work Plan, the applicable timelines shall bedeemed extended by a period of time corresponding to the length of such portion of the delay attributable to Stryker, on a day-by-day basis. The RD Work Plan may be amended by mutual written agreement of the Parties from time to time.2.2 Agents or Third Parties. To the extent working with Agents or other Third Parties is permitted under the RD WorkPlan, should a Party wish to engage an Agent or any other Third Party in connection with the RD Work Plan or any other workunder this Agreement, such Party must obtain in advance a written agreement by such Agent or other Third Party (i) to assign tothe Party all Inventions conceived, created or generated by the Agent or other Third Party, and (ii) to maintain all ConfidentialInformation in confidence as set forth in Section 5.2.ARTICLE IIIDELIVERABLES AND COMPLETION3.1 Deliverables. Subject to the remedies set forth in Section 3.4, Conformis shall furnish Stryker with the Deliverablesas defined in the RD Work Plan, and Stryker shall have the opportunity to analyze and test each Deliverable for the purposes ofdetermining Acceptance as set forth in the RD Work Plan. Each Deliverable shall be deemed to be completed once suchDeliverable has been Accepted (as defined below).3.2 Free from Infringement. Without the consent of Stryker, Conformis shall not introduce any structure ormethodology in the Deliverables (including a Deliverable within a Product or a Stryker Product) that (1) raise a colorableargument of patent infringement in the manufacture, use, sale, offer for sale or importation of the Deliverable as such Deliverable8Source: CONFORMIS INC, 10-Q, 11/1/2019is intended to be exploited under the Other Agreements, (2) misappropriate any Confidential Information of any Third Party, or(3) otherwise violate any Intellectual Property rights of any Third Party. For clarity, disclosure of a matter on the DisclosureSchedules to the Asset Purchase Agreement shall not be deemed consent by Stryker under this Section 3.2.3.3 Completion. After a Deliverable has been furnished to Stryker, Stryker (or its Agent designee) will be entitled toanalyze and test the Deliverable to determine if it operates in accordance with and otherwise conforms to the applicableAcceptance Criteria set forth in RD Work Plan. Conformis shall provide such assistance as Stryker may reasonably request insuch determination. Stryker shall have [] (“Acceptance Notification Period”) following the date the Deliverable is received byStryker to Accept or reject the Deliverable as described in Section 3.4.3.4 Acceptance or Rejection. Respecting any Deliverable for Milestone 1 or Milestone 2, as set forth below, ifStryker determines that a Deliverable operates in accordance with and otherwise conforms to the applicable Acceptance Criteriapursuant to the RD Work Plan, then Stryker will notify Conformis in writing that Stryker Accepts such Deliverable. If Strykerreasonably determines that a Deliverable does not operate in accordance with or otherwise conform to the applicable AcceptanceCriteria, then Stryker will provide Conformis with a written notice of rejection within the Acceptance Notification Perioddescribing the defect in view of the relevant Acceptance Criteria and including sufficient detail with respect to such Stryker testingand testing results as Conformis reasonably requests (“Failure Notice”). Conformis shall have [] (or such longer period of timeas may be agreed between the parties in good faith should the scope and complexity of the applicable Deliverable warrant somelonger period of time) (“Redelivery Period”) following the date it receives the Failure Notice to correct and redeliver theDeliverable. If Conformis timely delivers a corrected version of the Deliverable within the Redelivery Period, then Stryker will be9Source: CONFORMIS INC, 10-Q, 11/1/2019entitled to repeat its acceptance analysis and testing process for the purposes of determining Acceptance as set forth in the RDWork Plan until such Deliverable operates in accordance with or otherwise conforms to the applicable Acceptance Criteria;provided, however, that if Stryker properly rejects a particular Deliverable three (3) or more times in accordance with this ArticleIII, or if Conformis fails to deliver a version or corrected version, as the case may be, of the Deliverable within any respective []period, Stryker may, terminate this Agreement in accordance with Section 8.2(c) (in the event of such three (3) rejections, Stryker“Finally Rejects” the Deliverable). Such termination, together with the provisions of Section 5.2 of the License Agreement,constitutes as Stryker’s sole remedy and Conformis’ exclusive liability in the event of any such rejection or failure by Conformis todeliver materially conforming Deliverables hereunder so long as such rejection or failure does not arise from Conformis’ fraud,willful misconduct, gross negligence or bad faith. Stryker shall be deemed to have accepted a Deliverable timely furnished to itunless (a) the Deliverable fails to operate in accordance with and otherwise conform the applicable Acceptance Criteria, and (b)Stryker provides Conformis a written Failure Notice within the Acceptance Notification Period in accordance with this Section3.4 (any acceptance or deemed acceptance, described in this Section 3.4, “Acceptance” or “Accept”). Acceptance of aDeliverable shall not constitute a waiver of any rights Stryker may have based on Conformis’ warranties set forth in thisAgreement.3.5 Payment for Milestones. Stryker shall pay to Conformis the following milestone payments for the developmentwork to be conducted hereunder if and when the following milestones are met, as follows:(a) Milestone 1 - Within thirty (30) days following the date on which Stryker receives the first prototype of the Patient-Specific Instrumentation delivered to it by Conformis in accordance with the RD Work Plan, Stryker shall pay to Conformis atotal of two million U.S. dollars (2,000,000); and10Source: CONFORMIS INC, 10-Q, 11/1/2019(b) Milestone 2 - Within thirty (30) days following the date on which there is a design freeze of the Patient-SpecificInstrumentation for the KIB Product in accordance with the RD Work Plan, Stryker shall pay to Conformis a total of threemillion U.S dollars (3,000,000).3.6 Payment. Stryker shall make all payments to Conformis required herein by wire transfer in accordance with the WireInstructions. Such payments are non-refundable and non-creditable except as set forth in the Other Agreements.ARTICLE IVRESTRICTIVE COVENANT4.1 Exclusivity. Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited fromdeveloping or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-ShelfKnee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section2.3.3.4 or Section 2.3.5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in aChange of Control of Conformis, any such entity an “Acquirer”), may develop Patient-Specific Instrumentation for any Off-The-Shelf Implants of Conformis, an Acquirer or any of their Affiliates. For purposes of clarity, the foregoing does not preventConformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, includingany such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf KneeImplants outside the Buyer Field.ARTICLE VINTELLECTUAL PROPERTY5.1 Inventions.(a) Inventorship of all Inventions developed by either Party, or both Parties, in the performance of the RD Program, shallbe determined in accordance with the inventorship laws of the United States, even to the extent such Invention is not pursued inpatent applications.(b) All right, title and interest in and to the Improved Stryker Background IP will vest solely in Stryker. Conformis agreesto assign and hereby assigns to Stryker all right, title and interest in and to all Improved Stryker Background IP in which ownershipin same has vested in11Source: CONFORMIS INC, 10-Q, 11/1/2019Conformis by operation of law or by assignment by its employees or consultants; and to facilitate such assignment to Stryker,Conformis agrees (i) to regularly ensure that its employees and consultants timely make any appropriate assignments to it of thatwhich constitutes Improved Stryker Background IP, and (ii) at Stryker’s reasonable request, to execute and have its employeesand consultants execute, as necessary, all assignments and any other documentation necessary to perfect title in Stryker of suchImproved Stryker Background IP.(c) All right, title and interest in and to the Improved Conformis Background IP and KIB Product IP (“Joint IP”) shall beowned jointly by the Parties. Subject to the limitations set forth in this Agreement, the Joint IP may be used freely by either Party orits Affiliates and licensed to Third Parties by Conformis and its Affiliates, on the one hand, outside of the Buyer Field or by Strykerand its Affiliates, on the other hand, within the Buyer Field, in each case, without the consent of, or duty to account to or notify, theother Party, but, except with respect to external licenses of the Improved Conformis Background IP by Conformis or its Affiliatesto Third Parties, any external Third Party license shall be governed in accordance with the last sentence of Section 4.3(c) of theAPA. Each Party to whom ownership is to vest in Joint IP by operation of law or by assignment by its employees or Agents agreesto assign and hereby assigns to the other Party an undivided one-half right, title and interest in and to all Joint IP; and to facilitatesuch assignment, the Party possessing such ownership agrees (i) to regularly ensure that its employees and consultants timely makeany appropriate assignments to it; and (ii) at the other Party’s reasonable request, to execute and have its employees andconsultants execute, as necessary, all assignments and any other documentation to perfect the undivided one-half right, title andinterest in and to the other Party of such Joint IP.(d) Notwithstanding anything to the contrary, the foregoing does not constitute either (1) the grant by Conformis to Strykerof any license or immunity of any kind with respect to the Conformis Background IP or Conformis Foreground IP, regardless ofthe extent to which the Joint IP constitutes improvements to the Conformis Background IP or Conformis Foreground IP, (2) thegrant by Stryker to Conformis of any license or immunity of any kind with respect to the Stryker Background IP, or (3) the grantby either Party of any license or immunity of any kind under any Intellectual Property rights owned by such Party, regardless ofwhether the exploitation of the Joint IP would infringe such Intellectual Property rights. Neither Party shall assign a partial interest in12Source: CONFORMIS INC, 10-Q, 11/1/2019the Joint IP or Joint IP Rights to any Affiliate or Third Party (i.e., neither Party shall create any additional joint owners of the JointIP), but each Party may assign all of its right, title and interest in and to the Joint IP and Joint IP Rights to an Affiliate or Third Partypursuant to and in accordance with Section 10.2.(e) Conformis shall promptly disclose to Stryker all (i) Improved Stryker Background IP, and (ii) Joint IP. Stryker shallpromptly disclose to Conformis all Joint IP.(f) To the extent required and for the avoidance of doubt, Stryker hereby grants Conformis, and Conformis herebyaccepts, a non-exclusive license to the Stryker Background IP and Improved Stryker Background IP solely for purposes ofperforming any obligations under this Agreement and the Distribution Agreement.5.2 Confidential Information. The provisions of Sections 4.3(a)-(i) of Article 4 of the APA are incorporated herein as iffully set forth herein.5.3 Maintenance of Records. Each Party shall prepare and maintain complete and accurate records concerning allInventions for the purpose of documenting any possible Intellectual Property rights arising under this Agreement.5.4 No Other Rights.(a) Conformis acknowledges and agrees that, as between the Parties, Stryker owns all right, title and interest, including allIntellectual Property rights, within the Stryker Background IP and Stryker’s Confidential Information, including any StrykerConfidential Information underlying the Joint IP, and that, under this Agreement, except as expressly set forth herein, Conformisshall acquire no right, title, or interest in or to any of the foregoing, or any other Intellectual Property rights that are owned orcontrolled by Stryker, by implication, estoppel or otherwise.(b) Stryker acknowledges and agrees that, as between the Parties, Conformis owns all right, title and interest, including allIntellectual Property rights, in and to Conformis Background IP and Conformis’ Confidential Information, including any ConformisConfidential Information underlying the Joint IP, and that, under this Agreement, Stryker shall acquire no right, title, or interest in orto any of the foregoing or any other Intellectual Property rights that are owned or controlled by Conformis, by implication, estoppelor otherwise.5.5 Employees and Consultants.13Source: CONFORMIS INC, 10-Q, 11/1/2019(a) Conformis shall ensure that all its employees, consultants, Agents or other Third Parties who perform any portion ofConformis’ RD Program obligations under this Agreement have entered into written agreements with Conformis whereby suchemployee, consultant, Agent or other Third Party assigns to Conformis all ownership rights in any Inventions made or developedby such employee, consultant, Agent or Third Party in the course of such RD Program work under this Agreement.(b) Stryker shall ensure that all its Affiliates and its or their employees, consultants, Agents or other Third Parties who perform anyportion of Stryker’s RD Program obligations under this Agreement have entered into written agreements with Stryker wherebysuch employee, consultant, Agent or Third Party assigns to Stryker all ownership rights in any Inventions made or developed bysuch employee, consultant, Agent or Third Party in the course of such RD Program work under this Agreement.5.6 Tangible Property.(a) All tooling, patterns, dies, gauges, jobs, fixtures, and all specifications, drawings, samples, designs, software, firmware,programs, formulae, and other tangible items (“Equipment”) furnished by Stryker to Conformis in connection with thisAgreement: (i) shall only be used in the performance of the RD Program; (ii) shall remain the property of Stryker; and (iii) shallbe disposed of or returned in good repair, normal wear and tear excepted, by Conformis to Stryker at Stryker’s direction andexpense upon Stryker’s request. Conformis assumes risk of loss and damage to said items while in its possession or under itscontrol, subject to normal wear and tear. Conformis shall notify Stryker promptly whenever any items of Stryker’s tangibleproperty are in need of repair or replacement. Stryker shall endeavor to mark its property as property of Stryker for14Source: CONFORMIS INC, 10-Q, 11/1/2019use only under this Agreement. Conformis waives any right it may have in law or equity to withhold Stryker’s property.(b) All Equipment furnished by Conformis to Stryker in connection with this Agreement: (i) shall only be used in the performanceof the RD Program; (ii) shall remain the property of Conformis; and (iii) shall be disposed of or returned in good repair, normalwear and tear excepted, by Stryker to Conformis at Conformis’ direction and expense upon Conformis’ request. Stryker assumesrisk of loss and damage to said items while in its possession or under its control, subject to normal wear and tear. Stryker shallnotify Conformis promptly whenever any items of Conformis’ tangible property are in need of repair or replacement. Conformisshall endeavor to mark its property as property of Conformis for use only under this Agreement. Stryker waives any right it mayhave in law or equity to withhold Conformis’ property.5.7 Trademarks. Nothing in this Agreement shall confer to any Party any rights, whether by way of ownership, license orright to use, in any of the Trademarks of any other Party. Conformis shall not use the Trademarks of Stryker without Stryker’sprior written consent and Stryker shall not use the Trademarks of Conformis without Conformis’ prior written consent.5.8 Prosecution of Patent Rights. Stryker shall be solely responsible, in its sole discretion, for preparing, filing,prosecuting and maintaining Patents arising from all Improved Stryker Background IP. Stryker shall be solely responsible for costsand expenses of preparing, filing, prosecuting and maintaining any such Patents. Stryker shall have the first right to prepare, file,prosecute and maintain Patents or copyrights arising from any Joint IP that is not Improved Conformis Background IP (“Stryker-Prosecuted Joint IP Rights”). Conformis shall have the first right to prepare, file, prosecute and maintain Patents or copyrightsarising from any Improved Conformis Background IP (“Conformis-Prosecuted Joint IP Rights”, and together with the Stryker-Prosecuted Joint IP Rights, “Joint IP Rights”). With respect to Joint IP Rights, the non-prosecuting Party will have the right, butnot the obligation, to review and comment, and have the comments reasonably considered by the prosecuting Party, with regard tothe filing, prosecution,15Source: CONFORMIS INC, 10-Q, 11/1/2019and maintenance of the Joint IP Rights. In this regard, the prosecuting Party agrees to provide reasonable time for the non-prosecuting party to review and comment prior to any deadline associated with such Patent. Conformis and Stryker shall beequally responsible for costs and expenses of preparing, filing, prosecuting and maintaining any such Joint IP Rights.Notwithstanding the foregoing, in the event that the applicable Party decides not to file at all or not to file a continuing or otherapplication to maintain the viability of the U.S part of a family of patents to which an application belongs, or decides to abandon ordiscontinue the prosecution or maintenance of any of the Joint IP Rights, such Party shall notify the other Party thereof, and suchother Party may elect to continue the prosecution (including non-provisional application and PCT entry) or maintenance of suchJoint IP Rights at its sole expense and in the name(s) of both Stryker and Conformis. The provisions of Sections 5.1(c) and 5.1(d)and this Section 5.8 shall run with the Joint IP, and each party shall ensure that any assignee of its interest in the Joint IP expresslyassumes in writing such provisions. Any Party pursuing Patent applications in accordance with this Section 5.8 may discloseConfidential Information in patent applications to the extent necessary to provide requisite support for claims therein, providedhowever, the non-prosecuting Party will have the right, but not the obligation, to review and comment on the scope and content ofthe proposed disclosure, including the proposed disclosure of Confidential Information, prior to submission of the first disclosure ofsame in any such Patent applications, and have the comments reasonably considered by the prosecuting Party. In this regard, theprosecuting Party agrees to provide reasonable time for the non-prosecuting party to review and comment prior to any suchsubmission associated with such Patent.5.9 Infringement and Defense.(a) Each Party may in its sole discretion enforce the Patents or other intellectual property rights it solely owns pursuant tothis Agreement, as well as to defend against any assertions of invalidity, unenforceability or ownership of such Patents.(b) The Parties shall confer and consult with respect to disputes with Third Parties respecting the infringement, validity,enforceability or ownership of any Joint IP, including the settlement thereof. Such consultation shall be for the purpose ofdetermining the best approach within such actions and neither Party shall take any action to enforce or defend any Joint IP withoutthe other Party’s prior written consent.16Source: CONFORMIS INC, 10-Q, 11/1/20195.10 Publicity. Neither Party shall issue any press release or otherwise publicize this Agreement or the development workto be conducted hereunder, except in accordance with Section 4.2 of the APA.ARTICLE VIREPRESENTATIONS AND WARRANTIES6.1 Representations, Warranties and Covenants. Each Party hereby represents and warrants to, and covenants with,each other Party that:(a) Due Organization. Good Standing and Power. It is a corporation duly organized, validly existing and in good standing underthe laws of its jurisdiction of organization and has the power and authority to own, lease and operate its assets and to conduct thebusiness now being conducted by it. It has all requisite corporate power and authority to enter into this Agreement and to performits obligations hereunder.(b) Authorization and Validity of Agreement. The execution, delivery and performance by it of this Agreement and theconsummation by it of the transactions contemplated hereby have been duly authorized and approved by all necessary corporateor equivalent action on its part. This Agreement has been duly executed and delivered by it and constitutes its legal, valid andbinding obligation, enforceable against it in accordance with its terms, except as the same may be limited by applicablebankruptcy, insolvency, reorganization, moratorium or other Applicable Laws relating to or affecting creditors’ rights generally andby general equity principles.(c) Absence of Conflicts. The execution, delivery and performance by it of this Agreement and the consummation by it of thetransactions contemplated hereby do not and will not:(i) violate any Applicable Laws, regulations, orders, writs, injunctions or decrees of any governmental, judicial, legislative,executive, administrative or regulatory17Source: CONFORMIS INC, 10-Q, 11/1/2019authority of the United States or any foreign country or of any state or local governmental authority;(ii) conflict with, or result in the breach of any provision of, its certificate or articles of incorporation, bylaws or equivalentorganizational documents;(iii) result in the creation of any lien or encumbrance of any nature upon any property being transferred or licensed by itpursuant to this Agreement; or(iv) violate, conflict with, result in the breach or termination of or constitute a default under (or event which with notice, lapse oftime or both would constitute a default under), any permit, contract or agreement to which it is a Party or by which any of itsproperties or businesses are bound.(d) Consents. No authorization, consent or approval of, or notice to or filing with, any governmental authority is required for theexecution, delivery and performance by it of this Agreement, other than those associated with obtaining required regulatoryapprovals as contemplated hereby.(e) Employee and Consultant Obligations. Each of its employees, consultants and Agents who will engage in activities on behalf ofa Party under the RD Work Plan, or who will have access to Confidential Information, is contractually obligated, or will becontractually obligated prior to his/her participation or access, to (i) assign to the Party all Intellectual Property rights conceived,made or discovered by such employee or Agent, whether solely or in collaboration with others, in connection with suchemployee’s, consultant’s or Agent’s work for the Party, and (ii) maintain the confidentiality of the Confidential Information. To theextent applicable, it is the intent of the Parties that ownership of all developments under this Agreement shall vest in the respectiveParty by operation of law or by assignment prior to assignment to the other Party pursuant to Article V.18Source: CONFORMIS INC, 10-Q, 11/1/2019(f) Debarment. No employee, consultant or Agent who will engage in activities on behalf of such Party under the RDWork Plan, or who will have access to Confidential Information of the other Party, has been the subject of a debarment proceedingunder 21 U.S.C. § 335a, and has been excluded from participation in any Federal or State or other government health careprogram.6.2 EXCEPT AS EXPRESSLY PROVIDED ELSEWHERE IN THIS AGREEMENT, INCLUDING THEREQUIREMENTS IN THE RD WORK PLAN, CONFORMIS MAKES NO WARRANTY WITH RESPECT TO THESERVICES OR DELIVERABLES FURNISHED HEREUNDER, AND NO WARRANTIES OF ANY KIND, WHETHERWRITTEN, ORAL, IMPLIED OR STATUTORY, INCLUDING WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OR FITNESS FOR A PARTICULAR PURPOSE, SHALL APPLY.ARTICLE VIILIMITATION ON LIABILITY AND INDEMNIFICATION7.1 Responsibility and Control. Each Party shall be solely responsible for the safety of its own employees, Agents andsubcontractors with respect to their activities related to this Agreement.7.2 Limitation of Liability. EXCEPT FOR [], IN NO EVENT WILL EITHER PARTY BE LIABLE TO THEOTHER PARTY FOR [], EVEN IF SUCH PARTY WAS ADVISED OR AWARE OF THE POSSIBILITY OF SUCHDAMAGES. CONFORMIS’ LIABILITY ON A PER OCCURRENCE BASIS UNDER SECTION 7.3(A)(IV) SHALL NOTEXCEED THE GREATER OF (I) [] AND (II) THE AMOUNT OF INSURANCE COVERAGE ACTUALLY PAID TOCONFORMIS UNDER THEN-CURRENT INSURANCE POLICIES OF CONFORMIS IN RESPECT OF SUCHDAMAGES. For the purposes of this Section 7.2, “per occurrence” means the occurrence of any claim or series of claimsdirectly arising out of or resulting from the same act, omission or event.7.3 Mutual Indemnification.(a) Indemnification by Conformis. Conformis shall indemnify and hold harmless Stryker, its directors, officers, employees, Agentsand Affiliates and19Source: CONFORMIS INC, 10-Q, 11/1/2019their respective successors, heirs and assigns (collectively the “Stryker Indemnified Parties”) against any and all claims, suits,actions, and demands, wherever brought and however denominated, brought by a Third Party (all of the foregoing being referredto herein as “Claims”) against the Stryker Indemnified Party including all damages, collateral damages and settlements arisingtherefrom and reasonable outside attorneys’ fees and litigation expenses related thereto, to the extent arising from or related to (i)any breach of Conformis’ representations, warranties or obligations under this Agreement, (ii) any alleged violation of anyApplicable Laws by Conformis, (iii) the negligence (excluding any product liability Claim), gross negligence or intentionallywrongful acts or omissions of Conformis, its employees, consultants, Agents and Affiliates in their performance hereunder, and (iv)any portion of a Claim alleging personal injury on account of product liability attributable to a Deliverable (including a Deliverablewithin a Product or a Stryker Product). Conformis shall have no obligation or liability with respect to any Claim under Section7.3(a)(iii) or Section 7.3(a)(iv) to the extent directly arising out of or relating to: (1) any use of the Products in any manner not inaccordance with applicable documentation (e.g., instructions for use, package inserts, labels, surgical guides and other materialsprovided by or approved by Conformis) that is not a result of Conformis’ conduct; (2) damage to the Products occurring aftershipment that is not a result of Conformis’ conduct; or (3) any modifications to the Products that are not contemplated by theinstructions for use thereto by any Person other than Supplier and that is not a result of Conformis’ conduct. Notwithstandinganything to the contrary, Stryker’s sole remedy and Conformis’ exclusive liability for breach of Section 3.2 with respect to aProduct or a Stryker Product shall be as set forth in Section 10.1(i) of the Distribution Agreement.(b) Indemnification by Stryker. Stryker shall indemnify and hold harmless Conformis, its directors, officers, employees, Agentsand20Source: CONFORMIS INC, 10-Q, 11/1/2019Affiliates and their respective successors, heirs and assigns (collectively the “Conformis Indemnified Parties”) against any andall Claims against the Conformis Indemnified Parties to the extent arising from or related to (i) any breach of Stryker’srepresentations or warranties under this Agreement, (ii) any alleged violation of any Applicable Laws by Stryker, and (iii) thegrossly negligent or intentionally wrongful acts or omissions of Stryker, its employees, consultants, Agents and Affiliates in theirperformance hereunder.(c) Joint Liability. To the extent that Stryker, on the one hand, and Conformis, on the other hand, each has indemnificationobligations to the other in connection with a single Claim, they will contribute to the aggregate damages, liabilities, costs andexpenses arising from such Claim in a proportion reflecting the relative and comparative responsibilities and determined liability ofthe Parties for such damages, liabilities, costs and expenses, as well as any other relevant equitable considerations. The amountpaid or payable by a Party for purposes: of apportioning the aggregate damages, liabilities, costs and expenses shall be deemed toinclude all reasonable legal fees and expenses incurred by such Party in connection with investigating, preparing for or defendingagainst such Claim.(d) Indemnification Procedures. Claims for indemnification under this Agreement shall be governed by the indemnificationprocedures set forth in Section 5.5 of the Asset Purchase Agreement.(e) Settlement. If the indemnifying Party assumes the defense of a Claim, no compromise or settlement of such claims may beeffected by the indemnifying Party without the indemnified Party consent unless: (a) there is no finding or admission of any violationof Applicable Requirements or any violation of the rights of any Person by the indemnified Party and no effect on any other claimsthat may be made against the indemnified Party, (b) the sole relief provided is21Source: CONFORMIS INC, 10-Q, 11/1/2019monetary damages that are paid in full by the indemnifying Party and (c) such settlement includes as an unconditional release ofliability by such Third Party claimant in respect of all Indemnified Persons.ARTICLE VIIITERM AND TERMINATION8.1 Term. The term of this Agreement shall begin as of the Effective Date and continue until Acceptance of all Deliverablesfor Milestones 1 and 2 pursuant to Section 3.4 and completion of Milestone 3, unless earlier terminated under Section 8.2, asprovided for under the Other Agreements, or as mutually agreed by the Parties.8.2 Termination.(a) Dissolution or Insolvency Event. Either Party may terminate this Agreement effective immediately upon delivery of aTermination Notice if the other Party is (A) dissolved or is seeking to dissolve itself under applicable corporate law other than aspart of a corporate restructuring under which its assets were first transferred to an assignee under this Agreement in accordancewith Section 10.2; or (B) (i) becomes subject to an Insolvency Event, provided that, no termination right shall exist in respect of anInsolvency Event that is a chapter 11 case under the Bankruptcy Code if the Party subject to such chapter 11 case (x) continuesto perform all of its material obligations under this Agreement, (y) does not seek to reject this Agreement or take any action insuch chapter 11 case to disavow or undermine the rights of the other Party under this Agreement, and (z) assumes this Agreementon or before any deadline in such chapter 11 case for such assumption; notwithstanding the foregoing, nothing herein shall limit orprevent the Party not subject to an Insolvency Event from objecting to assumption or assumption and assignment of thisAgreement or requiring cure payments or adequate assurance22Source: CONFORMIS INC, 10-Q, 11/1/2019of future performance as a condition of assumption or assumption and assignment.(b) Default. If any Party believes the other is in material breach of any of its material obligations under this Agreement in amanner other than as set forth in Article III to which this Section 8.2(b) does not apply, it may give notice of such material breachto the allegedly breaching Party, which Party shall have [] (or such longer period of time as may be reasonably commensuratewith the effort reasonably required to remedy such default) in which to remedy such default. If such alleged material breach is notremedied in the time period set forth above, the Party alleging material breach shall refer the matter to the chief executive officersof each Party, who shall meet and confer within [] after notice from the non-breaching Party of its desire for such a meeting. Ifthe Parties are unable to resolve any dispute in such meeting and no Action has been brought in accordance with Section 10.8with respect to such dispute, the non-breaching Party may terminate this Agreement immediately upon delivery to the defaultingParty of a Termination Notice. The non-defaulting Party’s right to terminate this Agreement in accordance with this Section 8.2(b)shall not be construed as an exclusive remedy.(c) If Stryker Finally Rejects any Deliverable for Milestone 1 or 2 in accordance with Article III, Stryker may terminatethis Agreement, which termination shall be effective immediately upon delivery of a Termination Notice to Conformis.8.3 Surviving Rights/Obligations.(a) The provisions of Articles V, VI, VII and IX and Sections 8.3, 8.4, 10.1, 10.2, 10.5 - 10.13 and 10.15, together withany provisions required for the interpretation or enforcement of any of the foregoing, shall survive the termination or expiration ofthis Agreement, provided, however that Section 7.3(a)(iv) shall survive the termination or expiration of this Agreement for only[] thereafter. The termination of this Agreement shall not relieve any Party from obligations that are expressly indicated to survivetermination of the Agreement.23Source: CONFORMIS INC, 10-Q, 11/1/20198.4 Return or Destruction of Confidential Information. Solely with respect to Confidential Information in which aParty has no ownership interest at all, owned or co-owned Confidential Information being exempt herefrom, upon termination ofthis Agreement, unless independently authorized to retain such of the Disclosing Party’s Confidential Information under an OtherAgreement, each Receiving Party shall, and shall direct its Representatives to, cease all use and make no further use of anyConfidential Information of the Disclosing Party and shall, upon written request from the Disclosing Party, promptly return ordestroy all Confidential Information of the Disclosing Party (including copies thereof) that is in tangible form (provided, however,that, with respect to electronic imaging of the Disclosing Partys Confidential Information, such materials shall be deleted andremoved from access by an ordinary user from all computer hard drives, servers and similar media but shall not require any actionto delete or erase such materials from any disaster recovery tapes or other back-up media or any record retention or computerstorage system so long as the Receiving Party and its Representatives take such actions as are reasonably likely to prevent accessto such materials by any person other than information technology and other administrative employees who are responsible formaintaining those disaster recovery tapes and other back-up media) and any documents created by the Receiving Party or any ofits Representatives containing Confidential Information of the Disclosing Party. The Receiving Party shall provide to the DisclosingParty written certification of destroyed Confidential Information of the Disclosing Party promptly following the destruction thereof.Notwithstanding the foregoing, the Receiving Party and its Representatives may retain one copy of any Confidential Information ofthe Disclosing Party in a secure location in the Receiving Partys legal department for the purpose of establishing compliance withApplicable Laws (including professional standards) and for defending or maintaining any litigation (including any administrativeproceeding) relating to this Agreement, the Other Agreement, the Prior CDA or the Confidential Information, provided that all suchinformation shall continue to be kept confidential pursuant to the terms of this Agreement.24Source: CONFORMIS INC, 10-Q, 11/1/2019ARTICLE IXRECORD-KEEPING AND AUDITS9.1 Records Retention. Each of the Parties shall record in written or electronic form all material information with respectto the performance of its obligations relating to the RD Program in accordance with standard industry practices.ARTICLE XMISCELLANEOUS10.1 Agency. Neither this Agreement nor any of the Other Agreements creates any partnership, agency or otherrelationship among the Parties for any purpose, including for all tax purposes. No Party is granted any right or authority to assumeor to create any obligation or responsibility on behalf or in the name of the other Party or to bind the other Party in any mannerwhatsoever.10.2 Assignment and Change of Control. Except as otherwise provided herein, a Party shall not have the right toassign any of its rights or obligations under this Agreement (whether through a merger, sale of stock, or otherwise) without theprior written consent of the other Party; except that, either Party shall be permitted, without any need for the other Party’sconsent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer anAffiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party), provided that theassigning Party provides the other Party notice of any such assignment provided further that failure to provide such notice of suchassignment shall not render such assignment void; or (b) to a Third Party in connection with sale or transfer of all or substantially allof the assigning Party’s business or assets relating to the subject matter of this Agreement, whether by Change of Control, merger,sale of assets or otherwise; provided, however, that, with respect to clause (b), (i) any assignment of this Agreement shall be voidand have no effect unless and until the assignee assumes the25Source: CONFORMIS INC, 10-Q, 11/1/2019obligations of the assigning Party in a written instrument, a copy of which is provided to the other Party; and (ii) any assignment ofthis Agreement must be accompanied by a simultaneous assignment of the Other Agreements to the same assignee, and theassigning Party’s interest in the Purchased Assets to the same assignee unless otherwise agreed by Conformis in advance, whichagreement shall not be unreasonably withheld. Any assignment in whole or in part shall not relieve the assigning Party of itsobligations hereunder. If and to the extent that a Party assigns any of its rights and/or obligations hereunder in accordance with thisSection 10.2, then this Agreement shall be binding upon the assignee to the same extent as if it were a Party hereto. Anyassignment not in accordance with this Section 10.2 shall be void.10.3 Further Actions. Each Party agrees, subsequent to the execution and delivery of this Agreement and without anyadditional consideration, to execute, acknowledge and deliver such further documents and instruments, and to do all such otheracts, as may be necessary or appropriate in order to carry out the purposes and intent of this Agreement.10.4 Force Majeure.(a) In the event that either Party is unable to perform any of its obligations under this Agreement, or to enjoy any of itsbenefits because of fire, natural disaster, action or decrees of Governmental Entities or any other event not within such Party’sreasonable control (a “Force Majeure Event”), the Party who has been so affected shall give written notice to the other Party assoon as practicable and shall do everything reasonably possible to resume performance. Upon receipt of such notice, allobligations under the Agreement shall be immediately suspended. If the period of nonperformance exceeds [] from the receiptof notice of the Force Majeure Event, the Party whose ability to perform has not been so affected may, by giving written notice,terminate the Agreement. Any acceptance or warranty period affected by a Force Majeure Event shall likewise be extended for aperiod equal to the duration of such Force Majeure Event. As applied to this Section 10.426Source: CONFORMIS INC, 10-Q, 11/1/2019and to determine whether an event is reasonably beyond control of a Party, materials shortages, strikes, slowdowns, other laborrelated delays or events resulting from a Party’s, its Affiliates or their respective agents negligence, gross negligence, fraud orintentional misconduct are not Force Majeure Events.(b) Notwithstanding the provisions set forth in Section 10.4(a), above, a Force Majeure Event shall not include anygovernmental action of an enforcement nature that arises from or relates to either Party’s failure to comply with any federal,national, state, provincial, international, or local law, statute, regulation or ordinance applicable to such Party’s performancehereunder.10.5 Notices. All notices, requests, demands, waivers, instructions, consents and other communications to be givenpursuant to the terms of this Agreement will be in writing and will be deemed to have been duly given upon receipt if delivered byhand, sent by a nationally recognized overnight mail service, or mailed by registered or certified mail, return receipt requested,postage prepaid:If to Stryker, addressed to:Howmedica Osteonics Corp.c/oStryker CorporationAttn: Legal Department, []325 Corporate DriveMahwah, NJ 07430If to Conformis, addressed to:Conformis, Inc.Attn: Chief Executive Officer andGeneral Counsel600 Technology Park DriveBillerica, MA 01821With a copy (which shall not constitute notice) to:27Source: CONFORMIS INC, 10-Q, 11/1/2019WilmerHaleAttn: Jason Kropp, Esq.60 State StreetBoston, MA 02109Any Party may change its address, telephone number, or facsimile number by prior written notice to the other Party.10.6 Amendments and Waivers. This Agreement may not be modified or amended except by an instrument orinstruments in writing signed by the Party against whom enforcement of any such modification or amendment is sought. Conformismay waive compliance by Stryker or Stryker may waive compliance by Conformis with any term or provision of this Agreementon the part of such Party to be performed or complied with, but only by an instrument in writing. The waiver by any Party of abreach of any term or provision of this Agreement will not be construed as a waiver of any subsequent breach.10.7 Governing Law. This Agreement shall be governed and construed in accordance with the laws of New York State(without regard to the conflict of laws provisions thereof).10.8 Jurisdiction. Subject to Section 10.14, the federal and state Courts of New York State shall have exclusivejurisdiction to hear and decide any suit, Action or proceedings, and to settle any disputes, which may arise out of or in connectionwith this Agreement; provided, however, that each Party shall have the right to institute judicial proceedings in any court ofcompetent jurisdiction against the other Party or anyone acting by, through or under the other Party, in order to enforce an Orderentered by federal state courts of New York. Each Party shall cause its applicable permitted Third Party sublicensees andAffiliates receiving any rights or benefits (including the receipt of any Confidential Information) under this Agreement to be boundby this Section 10.8 prior to their exercise of any such rights or receipt of any such benefits. If such Party fails to comply with theforegoing sentence28Source: CONFORMIS INC, 10-Q, 11/1/2019with respect to any such Third Party or Affiliate, the other Party shall have the right to seek relief in any court of competentjurisdiction in connection with any dispute involving such Third Party or Affiliate.10.9 Severability. The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability ofany provision shall not affect the validity or enforceability of the other provisions hereof. If any term or other provision of thisAgreement, or the application thereof to any Person or any circumstance, is invalid, illegal or unenforceable by a Court ofcompetent jurisdiction, (a) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may bevalid and enforceable, the intent and purpose of such invalid or unenforceable provision and (b) the remainder of this Agreementand the application of such provision to other Persons or circumstances shall not be affected by such invalidity, illegality orunenforceability, nor shall such invalidity, illegality or unenforceability affect the validity or enforceability of such provision, or theapplication thereof, in any other jurisdiction.10.10 Entire Agreement and Third-Party Beneficiaries. This Agreement (including the Other Agreements) containsthe entire agreement by and among the Parties with respect to the subject matter hereof and there are no agreements,understandings, representations or warranties between the Parties other than those set forth or referred to herein. This Agreementis not intended to confer upon any Person not a party (or their successors and assigns permitted by Section 10.2), and to theextent expressly provided, their Affiliates, Agents, employees and representatives, any rights or remedies hereunder, except thatSection 7.3(a) and Section 7.3(b) hereof are intended to benefit, and to be enforceable by, any of the Relevant IndemnifiedParties therein described.10.11 Jointly Prepared. This Agreement has been prepared jointly and shall not be strictly construed against any Party.29Source: CONFORMIS INC, 10-Q, 11/1/201910.12 Expenses. Except as otherwise set forth in this Agreement and the Other Agreements, all legal and other costs andexpenses incurred in connection with this Agreement and the transactions contemplated hereby will be paid by the Party incurringsuch costs and expenses.10.13 Counterparts and Electronic Transmission. This Agreement may be executed in one or more counterparts, allof which will be considered one and the same agreement, and will become effective when one or more counterparts have beensigned by each of the Parties and delivered to the other Party. This Agreement may be executed and delivered by facsimile or e-mail transmission with the same effect as if a manually signed original was personally delivered.10.14 Negotiation in Event of Dispute. In the event of any dispute or disagreement between any of the Parties as tothe interpretation of any provision of this Agreement or any agreement incorporated herein, the performance of obligationshereunder or thereunder, or any other disputed matter relating hereto or thereto, such matter, upon the written request of anyParty, will be referred to an executive of each Party. Such executives will promptly meet in good faith to resolve the dispute. If theexecutives do not agree upon a decision within thirty calendar days after the reference of the matter to them, any Party will be freeto exercise any remedies available to it.10.15 Rules of Construction. As used in this Agreement, the words “include”, “includes” and “including” means“including without limitation”, and no inferences or conclusions of any sort shall be drawn from the fact that in some instances inthis Agreement the words “include”, “includes” and “including” are actually followed by the phrase “without limitation” or theequivalent while in other instances they are not. Except where the context expressly requires otherwise, the use of any genderherein will be deemed to encompass references to any gender, and the use of the singular will be deemed to include the plural (andvice versa).30Source: CONFORMIS INC, 10-Q, 11/1/2019[Signature Page Follows]31Source: CONFORMIS INC, 10-Q, 11/1/2019IN WITNESS WHEREOF, the parties have caused this Development Agreement to be duly executed as of the respectivedates written below.HOWMEDICA OSTEONICS CORP.CONFORMIS, INC.By:/s/ Spencer StilesBy:/s/ Mark A. AugustiName:Spencer StilesName:Mark A. AugustiTitle:PresidentTitle:President and CEODate:September 26, 2019Date:9-30-2019[Signature Page to Development Agreement]Source: CONFORMIS INC, 10-Q, 11/1/2019Execution VersionCertain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely causecompetitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.Source: CONFORMIS INC, 10-Q, 11/1/2019